CIK 0001706431 · Large accelerated filer
Vir Biotechnology, Inc.
Sign in to watch- Ticker
- VIR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 812730369
- Phone
- 415-906-4324
- Business address
- 1800 OWENS STREET, SUITE 900, SAN FRANCISCO, CA, 94158
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $41,939
- in 1 filing, $42K under 10b5-1 plans
Net −$41,939. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 46 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-10-19 | Virgin Herbert EVP, Research & CSO | Sale | −1,375 | $38.87 | $53K | 107,700 |
| 2021-10-19 | Virgin Herbert EVP, Research & CSO | Option exercise · Stock Option (Right to Buy) | −1,375 | 248,380 | ||
| 2021-10-19 | SATO VICKI L Director | Sale | −6,671 | $39.12 | $261K | 1,589,943 |
| 2021-10-19 | SATO VICKI L Director | Sale | −8,503 | $39.91 | $339K | 1,581,440 |
| 2021-10-06 | Pang Phillip Chief Medical Officer | Sale | −5,000 | $34.56 | $173K | 104,277 |
| 2021-10-05 | Virgin Herbert EVP, Research & CSO | Option exercise | +1,375 | $1.53 | $2K | 109,075 |
| 2021-10-05 | Virgin Herbert EVP, Research & CSO | Sale | −1,375 | $33.75 | $46K | 107,700 |
| 2021-10-05 | Virgin Herbert EVP, Research & CSO | Option exercise · Stock Option (Right to Buy) | −1,375 | 249,755 | ||
| 2021-09-27 | Pang Phillip Chief Medical Officer | Option exercise | +5,000 | $0.86 | $4K | 109,277 |
| 2021-09-27 | Pang Phillip Chief Medical Officer | Option exercise · Employee Stock Option (Right to Buy) | −5,000 | 18,833 | ||
| 2021-09-22 | Virgin Herbert EVP, Research & CSO | Option exercise | +8,000 | $1.53 | $12K | 107,700 |
| 2021-09-22 | Virgin Herbert EVP, Research & CSO | Option exercise · Stock Option (Right to Buy) | −8,000 | 251,130 | ||
| 2021-09-21 | Virgin Herbert EVP, Research & CSO | Option exercise | +4,125 | $1.53 | $6K | 103,825 |
| 2021-09-21 | Virgin Herbert EVP, Research & CSO | Sale | −4,125 | $50.00 | $206K | 99,700 |
| 2021-09-21 | Virgin Herbert EVP, Research & CSO | Option exercise · Stock Option (Right to Buy) | −4,125 | 259,130 | ||
| 2021-09-17 | SATO VICKI L Director | Sale | −11,775 | $52.31 | $616K | 1,600,013 |
| 2021-09-17 | SATO VICKI L Director | Sale | −3,399 | $53.06 | $180K | 1,596,614 |
| 2021-09-15 | Pang Phillip Chief Medical Officer | Sale | −4,280 | $49.58 | $212K | 104,997 |
| 2021-09-15 | Pang Phillip Chief Medical Officer | Sale | −720 | $50.36 | $36K | 104,277 |
| 2021-09-07 | Virgin Herbert EVP, Research & CSO | Option exercise | +4,125 | $1.53 | $6K | 103,825 |
Page 35 of 54 · 1,063 trades